Loading company details...
Latest Form 4 (Nov 13, 2026): Elisha W. Finney (Director): Exercise/Conversion of 65 shares, $10.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | Elisha W. Finney | Exercise/Conversion | 65 | $10.3K |
| Sep 3, 2026 | Virginia Ruth Sanzone, VP, General Counsel | Sale | 2,202 | $369.2K |
| Sep 1, 2026 | Brian Michael Bonnell, Chief Financial Officer | Sale | 6,381 | $1.12M |
| Aug 31, 2026 | Brian Michael Bonnell, Chief Financial Officer | Sale | 1,712 | $292.8K |
| Aug 13, 2026 | Daniel Woolson, VP, GM-Infusion Capital | Sale | 5,417 | $982.3K |
| Aug 12, 2026 | Ben Sousa, Chief Information Officer | Sale | 2,250 | $401.2K |
| Aug 11, 2026 | Christian B. Voigtlander, Chief Operating Officer | Sale | 8,929 | $1.63M |
| Aug 11, 2026 | Elisha W. Finney | Sale | 378 | $69.0K |
| May 22, 2026 | Daniel Woolson, President | Sale | 2,123 | $280.7K |
| May 15, 2026 | Virginia Ruth Sanzone, VP, General Counsel | Sale | 2,447 | $303.6K |